MiR-223-3p was able to inhibit RIPK3 by targeting the 3′ untranslated region of RIPK3 to inhibit RIPK3 expression and mitigate 3-MCPD-dipalmitate-induced AKI.[70]. This evidence concerns the gene RIPK3 and acute kidney injury.